Publicaciones en colaboración con investigadores/as de Queen Mary University of London (10)

2023

  1. Author Correction: Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth (Nature Communications, (2020), 11, 1, (2810), 10.1038/s41467-020-16618-6)

    Nature Communications

2021

  1. Improved immunotherapy efficacy by vascular modulation

    Cancers, Vol. 13, Núm. 20

2020

  1. Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells

    Cell, Vol. 181, Núm. 6, pp. 1346-1363.e21

  2. Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth

    Nature Communications, Vol. 11, Núm. 1

  3. “Splitting the matrix”: intussusceptive angiogenesis meets MT1-MMP

    EMBO Molecular Medicine

2019

  1. Novel Pure αvβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations

    ACS Pharmacology and Translational Science, Vol. 2, Núm. 6, pp. 387-401

2018

  1. Impaired erythropoietin synthesis in chronic kidney disease is caused by alterations in extracellular matrix composition

    Journal of Cellular and Molecular Medicine, Vol. 22, Núm. 1, pp. 302-314

2017

  1. Dual role of pericyte α6β1-integrin in tumour blood vessels

    Journal of Cell Science, Vol. 130, Núm. 9, pp. 1583-1595

  2. Overcoming the Lack of Oral Availability of Cyclic Hexapeptides: Design of a Selective and Orally Available Ligand for the Integrin αvβ3

    Angewandte Chemie - International Edition, Vol. 56, Núm. 51, pp. 16405-16409

2016

  1. Overexpression of the short endoglin isoform reduces renal fibrosis and inflammation after unilateral ureteral obstruction

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 9, pp. 1801-1814